Researchers are increasingly focused on retatrutide, a promising medication from Eli Lilly, as a significant breakthrough in physique loss . Unlike many earlier approaches, retatrutide is a dual -action compound targeting equally GLP-1 and GIP, chemicals that impact satiety and blood glucose bala